Jiangsu Hanbon Science and Technology
688755
ZERUN CO., LTD
301636
SENXUAN
830946
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -26.31%138.08M | -22.55%807.39M | -19.54%657.47M | -14.04%430.57M | -7.96%187.38M | 4.22%1.04B | -1.33%817.14M | -1.37%500.88M | -18.06%203.59M | -16.55%1B |
Operating revenue | -26.31%138.08M | -22.55%807.39M | -19.54%657.47M | -14.04%430.57M | -7.96%187.38M | 4.22%1.04B | -1.33%817.14M | -1.37%500.88M | -18.06%203.59M | -16.55%1B |
Other operating revenue | ---- | -18.46%19.65M | ---- | -13.34%12.02M | ---- | -22.11%24.1M | ---- | -39.20%13.88M | ---- | 6.81%30.95M |
Total operating cost | -14.83%199.4M | -9.91%1.04B | 1.74%764.01M | 6.70%512.2M | -0.15%234.12M | 13.56%1.16B | -5.17%750.98M | -1.86%480.02M | -3.75%234.47M | 0.65%1.02B |
Operating cost | -9.70%112.98M | -12.18%591.8M | 2.91%426.57M | 10.81%288.7M | -5.04%125.12M | 17.65%673.9M | -10.18%414.5M | -9.20%260.54M | -8.22%131.77M | -1.56%572.79M |
Operating tax surcharges | -10.69%2.41M | 13.61%14.78M | 15.76%11.17M | 25.18%8.49M | -8.90%2.69M | 9.14%13.01M | 8.47%9.65M | 9.41%6.79M | 10.91%2.96M | -17.57%11.92M |
Operating expense | -48.40%5.48M | -41.83%37.28M | -17.09%30.4M | -15.65%20.93M | 2.75%10.61M | 15.99%64.1M | -2.91%36.66M | 9.64%24.81M | 0.53%10.33M | -5.98%55.26M |
Administration expense | -17.88%59.75M | 5.42%311.85M | 2.20%221.92M | 3.08%144.34M | 7.86%72.76M | 11.38%295.82M | 7.98%217.15M | 13.67%140.03M | 6.56%67.46M | 0.72%265.59M |
Financial expense | -7.74%18.78M | -14.11%85.1M | 1.65%64.83M | 4.58%44.19M | 4.23%20.35M | 5.33%99.08M | -4.29%63.77M | 12.71%42.25M | 13.11%19.53M | 49.72%94.07M |
-Interest expense (Financial expense) | -2.37%18.63M | -13.60%80.74M | 15.03%60.93M | 21.27%41.45M | 4.82%19.08M | 1.45%93.45M | -7.48%52.97M | -3.52%34.18M | 12.06%18.2M | 55.13%92.12M |
-Interest Income (Financial expense) | -845.80%-1.25M | 81.77%-378.24K | 83.01%-286.23K | 72.95%-205.28K | 71.48%-131.93K | -14.14%-2.07M | -22.45%-1.68M | -3.40%-758.88K | 78.11%-462.59K | 47.83%-1.82M |
Research and development | ---- | -77.63%2.8M | -1.26%9.12M | -1.06%5.54M | 6.36%2.57M | -38.88%12.51M | -42.31%9.24M | -55.74%5.6M | -62.82%2.42M | -35.82%20.47M |
Credit Impairment Loss | -61.25%50.78K | -79.58%-90.8M | -29.33%-28.18M | 53.85%-6.74M | 20.25%131.06K | -691.62%-50.56M | -655.06%-21.79M | -3,182.24%-14.61M | 221.00%108.99K | -49.29%-6.39M |
Asset Impairment Loss | ---- | -89.47%-316.48M | ---- | ---- | ---- | -465.23%-167.03M | --268.8K | --235.2K | ---- | -401.93%-29.55M |
Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
Other net revenue | 8.97%4.81M | -95.03%-413.86M | -207.06%-22.6M | 17.59%-3.53M | -51.22%4.42M | -968.65%-212.21M | -170.39%-7.36M | -134.80%-4.28M | 143.91%9.05M | -372.69%-19.86M |
Invest income | -145.70%-419.35K | -20.91%-15.82M | 326.11%1.01M | 235.45%691.9K | 619.23%917.71K | -958.50%-13.08M | -127.12%-447.14K | -125.47%-510.82K | -107.94%-176.75K | 154.88%1.52M |
-Including: Investment income associates | ---- | 88.49%-1.51M | ---- | ---- | ---- | -762.59%-13.08M | ---- | ---- | ---- | 23.05%-1.52M |
Asset deal income | 2,119.15%1.13M | -105.94%-220.53K | -355.43%-1.74M | -324.22%-1.68M | -84.84%51.01K | 643.98%3.71M | 187.07%682.99K | 247.05%748.68K | 4,064.86%336.44K | 93.97%-682.81K |
Other revenue | 22.09%4.05M | -35.93%9.45M | -54.63%6.32M | -57.39%4.2M | -62.25%3.32M | -3.19%14.75M | 11.62%13.93M | -12.50%9.85M | 501.04%8.78M | -20.78%15.24M |
Operating profit | -33.48%-56.5M | -98.09%-650.09M | -319.62%-129.14M | -613.76%-85.16M | -93.94%-42.33M | -725.09%-328.18M | 25.81%58.8M | -46.65%16.58M | -354.85%-21.82M | -122.00%-39.78M |
Add:Non operating Income | -94.81%8.96K | -34.67%304.47K | -6.08%439.72K | -13.30%193.14K | 1,514.07%172.72K | -28.43%466.03K | -26.47%468.2K | -66.01%222.75K | -97.81%10.7K | -97.18%651.15K |
Less:Non operating expense | -73.73%123.49K | 20,819.97%328.61M | 337.99%3.16M | 143.94%1.33M | 171.93%470.1K | -43.75%1.57M | -57.94%721.29K | -60.18%543.48K | 1.94%172.88K | -67.37%2.79M |
Total profit | -32.82%-56.62M | -197.12%-978.39M | -325.21%-131.86M | -630.86%-86.29M | -93.87%-42.63M | -685.58%-329.29M | 28.22%58.55M | -46.45%16.25M | -347.50%-21.99M | -121.45%-41.92M |
Less:Income tax cost | 43.98%-93.19K | -174.98%-34.31M | -103.34%-1.31M | -99.95%9.76K | -103.99%-166.33K | 40.58%45.76M | 31.77%39.32M | 12.64%21.04M | -47.97%4.17M | -50.84%32.55M |
Add:Adjusted items effecting net profit | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net profit | -33.12%-56.52M | -151.72%-944.08M | -779.00%-130.55M | -1,702.16%-86.3M | -62.33%-42.46M | -403.64%-375.05M | 21.54%19.23M | -141.01%-4.79M | -3,101.16%-26.16M | -157.65%-74.47M |
Net profit from continuing operation | -33.12%-56.52M | -151.72%-944.08M | -779.00%-130.55M | -1,702.16%-86.3M | -62.33%-42.46M | -403.64%-375.05M | 21.54%19.23M | -141.01%-4.79M | -3,101.16%-26.16M | -157.65%-74.47M |
Less:Minority Profit | -15.67%-8.51M | -211.93%-41.53M | -3,055.31%-21.07M | -685.19%-13.59M | -253.08%-7.35M | 7.98%-13.31M | 111.97%713.09K | 147.08%2.32M | 70.35%-2.08M | -214.74%-14.47M |
Net profit of parent company owners | -36.78%-48.02M | -149.51%-902.56M | -691.32%-109.48M | -922.68%-72.71M | -45.83%-35.11M | -502.89%-361.74M | -14.98%18.51M | -142.81%-7.11M | -404.93%-24.07M | -144.86%-60M |
Earning per share | ||||||||||
Basic earning per share | -40.00%-0.07 | -150.00%-1.25 | -600.00%-0.15 | -900.00%-0.1 | -66.67%-0.05 | -525.00%-0.5 | 0.00%0.03 | -150.00%-0.01 | -400.00%-0.03 | -144.44%-0.08 |
Diluted earning per share | -40.00%-0.07 | -150.00%-1.25 | -600.00%-0.15 | -900.00%-0.1 | -66.67%-0.05 | -525.00%-0.5 | 0.00%0.03 | -150.00%-0.01 | -400.00%-0.03 | -144.44%-0.08 |
Other composite income | ||||||||||
Total composite income | -33.12%-56.52M | -151.72%-944.08M | -779.00%-130.55M | -1,702.16%-86.3M | -62.33%-42.46M | -403.64%-375.05M | 21.54%19.23M | -141.01%-4.79M | -3,101.16%-26.16M | -157.65%-74.47M |
Total composite income of parent company owners | -36.78%-48.02M | -149.51%-902.56M | -691.32%-109.48M | -922.68%-72.71M | -45.83%-35.11M | -502.89%-361.74M | -14.98%18.51M | -142.81%-7.11M | -404.93%-24.07M | -144.86%-60M |
Total composite income of minority owners | -15.67%-8.51M | -211.93%-41.53M | -3,055.31%-21.07M | -685.19%-13.59M | -253.08%-7.35M | 7.98%-13.31M | 111.97%713.09K | 147.08%2.32M | 70.35%-2.08M | -214.74%-14.47M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Adverse Opinion | -- | -- | -- | Adverse Opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Beijing Dehao International Accounting Firm (Special General Partnership) | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.